Author

M. S. Rogers

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

D. Sim· 2 shared A. C. Andrello· 1 shared A. F. Vitonis· 1 shared A. L. Blois· 1 shared D. Bree· 1 shared D. R. Bielenberg· 1 shared H. Bukhari· 1 shared K. L. Terry· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

D. Sim

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Targeting NGF but not VEGF or BDNF signaling reduces endometriosis-associated pain in mice

T. H. Zaninelli, V. Fattori, O. K. Heintz, K. R. Wright, P. R. Bennallack, D. Sim, H. Bukhari, K. L. Terry, A. F. Vitonis, S. A. Missmer, A. C. Andrello, R. Anchan, S. K. Godin, D. Bree, W. A. Verri, M. S. Rogers

This study shows that blocking NGF-TrkA signaling reduces endometriosis-associated pain in mice, while blocking VEGF-VEGFR1 or BDNF-TrkB does not.

bioRxiv · Dec 5, 2023 · PreprintPharmacology & Toxicology

Notch1 regulates breast cancer stem cell function via a non-canonical cleavage-independent pathway

L. Sui, S. Wang, R. K. Rodriguez, D. Sim, N. Bhattacharya, A. L. Blois, T. Schlaeger, S. Chen, S. Aziz, M. S. Rogers, D. R. Bielenberg, L. A. Akslen, R. S. Watnick

This study identifies a non-canonical Notch1 pathway that represses SIRT1 to drive tumor initiation and chemoresistance in breast cancer stem cells.

bioRxiv · Feb 28, 2020 · PreprintCancer Biology